Caren Sourij

Graz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Safety and efficacy of intermittent fasting with or without exercise in people living with overweight or obesity and type 2 diabetes-The INTERFAST-3 study design.

Safety and efficacy of intermittent fasting with or without exercise in people living with overweight or obesity and type 2 diabetes-The INTERFAST-3 study design.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: December 19, 2025

Decision accuracy of simultaneously used real-time CGM versus intermittently scanned CGM around exercise in type 1 diabetes: A secondary analysis of the ULTRAFLEXI-1 study.

Decision accuracy of simultaneously used real-time CGM versus intermittently scanned CGM around exercise in type 1 diabetes: A secondary analysis of the ULTRAFLEXI-1 study.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: October 16, 2025

Impact of intermittent fasting on self-regulatory behaviour and sleep in participants with insulin-treated type 2 diabetes: A secondary analysis of the INTERFAST-2 randomised controlled trial.

Impact of intermittent fasting on self-regulatory behaviour and sleep in participants with insulin-treated type 2 diabetes: A secondary analysis of the INTERFAST-2 randomised controlled trial.

Journal: Diabetes, obesity & metabolism

Published: October 09, 2025

Acute and prolonged effects of aerobic endurance training on N-lactoyl-phenylalanine and inflammatory markers in individuals with type 1 diabetes: An exploratory analysis of the ULTRAFLEXI-1 study.

Acute and prolonged effects of aerobic endurance training on N-lactoyl-phenylalanine and inflammatory markers in individuals with type 1 diabetes: An exploratory analysis of the ULTRAFLEXI-1 study.

Journal: Diabetes, obesity & metabolism

Published: July 11, 2025

IL-10- and IL-13-Biased T Cell Responses to SARS-CoV-2 Vaccination in Diabetes.

IL-10- and IL-13-Biased T Cell Responses to SARS-CoV-2 Vaccination in Diabetes.

Journal: European journal of immunology

Published: May 08, 2025

Interplay of health-related quality of life and comorbidities in people with type 2 diabetes mellitus treated in primary care settings in Austria: a countrywide cross-sectional study.

Interplay of health-related quality of life and comorbidities in people with type 2 diabetes mellitus treated in primary care settings in Austria: a countrywide cross-sectional study.

Journal: BMJ open

Published: April 15, 2025

Prevalence of Undiagnosed Diabetes and Prediabetes according to Age and Obesity Status in Central Europe.

Prevalence of Undiagnosed Diabetes and Prediabetes according to Age and Obesity Status in Central Europe.

Journal: Obesity facts

Published: April 10, 2025

Impact of level 2 hypoglycaemia on neuroaxonal damage biomarker in individuals with type 2 diabetes: A stepwise hypoglycaemic clamp study.

Impact of level 2 hypoglycaemia on neuroaxonal damage biomarker in individuals with type 2 diabetes: A stepwise hypoglycaemic clamp study.

Journal: Diabetes, obesity & metabolism

Published: January 30, 2025

Air Pollution and Myocardial Infarction-A New Smoker's Paradox?

Air Pollution and Myocardial Infarction-A New Smoker's Paradox?

Journal: Journal of clinical medicine

Published: October 25, 2024

Sustained weight reduction following 12 weeks of intermittent fasting intervention in people with insulin-treated type 2 diabetes-Two-year follow-up of the randomised controlled InterFast-2 trial.

Sustained weight reduction following 12 weeks of intermittent fasting intervention in people with insulin-treated type 2 diabetes-Two-year follow-up of the randomised controlled InterFast-2 trial.

Journal: Diabetes, obesity & metabolism

Published: October 04, 2024

Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT study.

Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT study.

Journal: Diabetes, obesity & metabolism

Published: July 30, 2024

Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial.

Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial.

Journal: Diabetes, obesity & metabolism

Published: December 23, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026